New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Jarrow challenges FDA hiring of Daniel Fabricant

Jarrow L. Rogovin sent Dr. Margaret Hamburg a letter strenuously opposing the FDA’s hiring of Daniel Fabricant, Ph.D., formerly a top executive at the Natural Products Association.


Jarrow L. Rogovin, Founder, President and Chairman of the Board of Jarrow Formulas, Inc., and Chairman of the Board of Jarrow Industries, Inc., sent Dr. Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration; a letter strenuously opposing the FDA’s hiring of Daniel Fabricant, Ph.D., formerly a top executive at the Natural Products Association (NPA, previously NNFA). The letter asserts that Dr. Fabricant gained access to proprietary and confidential industry “trade secrets” and was bound to keep that information private, and as such, has a deeply rooted and irreconcilable conflict of interest in his role as the FDA’s new Director of Dietary Supplement Programs.

“Because of his past employment with the Natural Products Association (NPA) as Vice President of Scientific and Regulatory Affairs, and one year as its acting CEO, Dr. Fabricant has an insurmountable conflict of interest,” said Jarrow L. Rogovin. “This should be obvious to anyone involved in the industry including anyone at the FDA.”

Mr. Rogovin’s letter Re: FDA’s hiring of Dr. Fabricant is a prelude to Jarrow Formulas’ campaign to challenge the FDA’s “Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.” Jarrow Formulas has also submitted a 16-point letter to the FDA requesting an extension to the NDI Draft Guidance comment period, from 90 days to one-year (ending July 5, 2012). Jarrow Formulas is also filing comments to the FDA via Docket No. FDA-2011D-0376. Link to post comments to the FDA regarding the NDI Draft Guidance:;D=FDA-2011-D-0376-0001

Jarrow Formulas urges those who care about access to dietary supplements to take action and let their elected officials know they will not tolerate the FDA over-regulating dietary supplements. Jarrow Formulas has created the following page as an action resource:


Jarrow Formulas is based in Los Angeles, California, and is a formulator and supplier of superior nutritional supplements. The company was founded in 1977 and today markets its products in the United States and throughout the world. Jarrow Formulas' goal is to promote optimal health based on sound scientific research data. The company’s complete line of nutritional products includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition products.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.